- Change Language
- Home
- Overview
- Subscribers
- Locations
- Newsroom
The U.S. Food and Drug Administration (FDA) has given emergency use authorization (EUA) for the drug tocilizumab (trade name Actemra) to be used in treating COVID-19 patients. If may be used for any hospitalised patient 2 years and older who requires oxygen treatment or ventilation and is also receiving corticosteroids. Previously reported trials have found that treatment with tocilizumab and corticosteroids could reduce the risk of death and length of hospitalisation in clinical trials.
Pandemic Information Webinars
(Available to Pandemic Subscribers only)
Register for upcoming events
View/Download previous webinars
Additional data provided by
English
Japanese
